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insomnia and sleep disturbances. Parametric and nonparametric test
were used to compare differences between and within groups.
Results: In our study, adolescents with CFS stayed in bed longer
and had a signiﬁcantly delayed mid sleep time during work days
compared to the healthy controls. Further, adolescents with CFS also
scored signiﬁcantly worse on insomnia (mean 3.4 vs 4.9), sleepiness
(mean 3.7 vs 5.0) and awakening problems (mean 2.5 vs 4.9) on
KSQ. Moreover, they report longer sleep onset latency than healthy
controls (mean 75 min vs 31 min).
Conclusions: Our ﬁndings suggest that adolescents with CFS
subjectively have more insomnia-, sleepiness- and awakening
symptoms than their healthy peers. Objectively we found a sleeping
pattern that indicates delayed sleep rhythm.
Disclosure: Nothing to disclose.
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Circadian rhythms in patients suffering from disorders of conscious-
ness (DOC) are likely to yield diagnostic and prognostic value. Eye
opening and closing might correlate with sleep-wake cycles yet are
too inaccurate in order to draw a conclusive picture.
Here, we studied 24 h hours EEG recordings in two lights condition in
a sample of 35 patients (18 UWS, 17 MCS). Additionally, 8 h healthy
recording containing both wake periods and sleep, were performed.
We analysed EEG complexity by using Permutation Entropy (PE) on
12 scalp electrodes. PE estimates complexity by extracting speciﬁc
patterns from the signal and quantifying their probability of occur-
rence. PE can be seen as way to quantify the number of patterns
present in the signal rather than their magnitude.
Across all groups, the ‘rest state’ (light OFF in VS/UWS, MCS and
sleep in healthy) was characterized by reduced PE compared to the
‘active’ (light ON in VS/UWS, MCS and wake in healthy). Especially
the difference between rest and active state was strongest for healthy
individuals (t25 = 9.070, P < 0.001, r = 0.88), followed by MCS
(t16 = 2.438, P = 0.027, r = 0.52) and smallest, yet marginally
signiﬁcant for VS/UWS (t17 = 1.795, P = 0.091, r = 0.4).
Results suggest preserved, however impaired, circadian reactivity in
patients, with VS/UWS patients showing the strongest deterioration
of the sleep-wake cycle. Present results add to a recent study by Thul
et al. (2016) who have shown reduced EEG complexity in DOC
patients during the active waking state.
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Objectives: Fatigue is a frequent and distressing symptom in
patients with multiple sclerosis (MS). In contrast, sleepiness, char-
acterized by difﬁculties to stay awake and alert during the day, seems
to be less prevalent in MS; however exact studies are lacking. In
addition, there is a semantic confusion of the concepts of “fatigue”
and “sleepiness”, which are often used interchangeably.
Methods: We conducted a systematic review of studies using the
Epworth Sleepiness Scale (ESS) for the assessment of daytime
sleepiness in patients with MS.
Results: The summarized results of 48 studies demonstrate that
sleepiness, as indicated by elevated ESS scores, is less prevalent
and less severe than fatigue but is present in a signiﬁcant proportion
of patients with MS. In most cross-sectional and longitudinal studies,
there was a moderate association between ESS scores and various
fatigue rating scales. Longitudinal studies on the effect of wakeful-
ness-promoting agents failed to show a consistent improvement of
sleepiness or fatigue as compared to placebo. It has also been
shown that daytime sleepiness is frequently associated with comor-
bid sleep disorders that are often underrecognized and undertreated
in MS.
Conclusions: Sleepiness and potential sleep disorders may also
precipitate and perpetuate fatigue in patients with MS and should be
part of the differential diagnostic assessment. To support an appro-
priate decision-making process, we propose an algorithm for the
evaluation of sleepiness as compared to fatigue in patients with MS.
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ICU survivors perceived persistent reduction in quality of life with
signiﬁcant sleep complains. However, studies examining sleep in
ICU survivors after hospital discharge are lacking. Thus, we
evaluated the sleep architecture in ICU survivors within 72 h and at
6 months after hospital discharge.
Overnight polysomnography was performed in eligible ICU survivors
without history of sleep disorders within 72 h (1st-evaluation) and at
6 months (2nd-evaluation) after hospital discharge.
Twenty-seven patients, (80% had acute-respiratory-distress-syn-
drome during ICU stay) were studied. Eight patients were lost to
follow-up and thus the results of the 2nd-evaluation pertain to 19
patients. At 1st-evaluation sleep architecture was poor, characterized
by normal sleep efﬁciency, high percentage of N1 [27.9% (21.4–
36.0), median (interquartile range)] and low N3 [4.6% (0.5–5.9)] and
REM [6.0% (1.0–15.7)]. Twenty-one patients (77.8%) exhibited mild
(n = 4), moderate (n = 11) or severe (n = 6) sleep-apnea-syndrome
of obstructive (OSAS, n = 20) or central type (n = 1). Compared to
1st-evaluation, at 2nd-evaluation apnea-hypopnea-index decreased
signiﬁcantly [(23.6 (15.8–27.7) vs. 11.0 (4.7–16.3) events/hour], while
the other indices of sleep architecture did not change. At 2nd-
evaluation 6 out of 19 patients (32%) exhibited moderate (n = 4) or
severe (n = 2) OSAS, signiﬁcantly less than these at 1st-evaluation
[14 out of 19 (74%), moderate n = 9, severe n = 5, all OSAS].
At hospital discharge the majority of ICU survivors exhibited
moderate to severe OSAS which improved signiﬁcantly within
6 months, and persistent poor sleep quality. Reversible critical
illness polyneuropathy and/or morphological upper airways abnor-
malities could contribute to syndrome development.
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